ConductScience.org, home

Paper8437232

Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans.

Holmbäck K and 5 others. J Virol, 1993. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans. Papers, record 8437232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8437232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans.
PubMed
Journal
J Virol
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2020-07-24
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Holmbäck KK
2Kusk PP
3Hulgaard EFE F
4Bugge THT H
5Scheibel EE
6Lindhardt BOB O

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV AntibodiesMajor topic
HIV Envelope Protein gp120Major topic
HIV InfectionsMajor topic
HIV-1Major topic
Amino Acid Sequence
Antibodies, Heterophile
Base Sequence
Cloning, Molecular
Cross Reactions
Genetic Variation
Hemophilia A
Humans
Molecular Sequence Data
Oligodeoxyribonucleotides
Polymerase Chain Reaction
Recombinant Proteins
Sequence Alignment
Sequence Analysis, DNA

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12452447Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2452447PubMed
22450351Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2450351PubMed
32455899Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2455899PubMed
42456084Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition.AIDS1988https://conductscience.org/library/papers/2456084PubMed
53405290Extensive variation of human immunodeficiency virus type-1 in vivo.Nature1988https://conductscience.org/library/papers/3405290PubMed
62845130Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4.J Virol1988https://conductscience.org/library/papers/2845130PubMed
72469437Antibody response to a synthetic peptide covering a LAV-1/HTLV-IIIB neutralization epitope and disease progression.AIDS1989https://conductscience.org/library/papers/2469437PubMed
82771954Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2771954PubMed
91967191The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.N Engl J Med1990https://conductscience.org/library/papers/1967191PubMed
102328092Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.AIDS1990https://conductscience.org/library/papers/2328092PubMed
112190095Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.Nature1990https://conductscience.org/library/papers/2190095PubMed
121693639Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual.J Immunol1990https://conductscience.org/library/papers/1693639PubMed
132355006
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
J Biol Chem1990https://conductscience.org/library/papers/2355006PubMed
142370678Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.J Virol1990https://conductscience.org/library/papers/2370678PubMed
152370681Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1 IIIB infection of chimpanzees.J Virol1990https://conductscience.org/library/papers/2370681PubMed
161696634Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.J Virol1990https://conductscience.org/library/papers/1696634PubMed
172392685Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.Science1990https://conductscience.org/library/papers/2392685PubMed
181700435Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/1700435PubMed
192243378Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1.J Virol1990https://conductscience.org/library/papers/2243378PubMed
201988952Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.Proc Natl Acad Sci U S A1991https://conductscience.org/library/papers/1988952PubMed

See all 37 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
9094648Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.J Virol1997https://conductscience.org/library/papers/9094648PubMed
8189527Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum.J Virol1994https://conductscience.org/library/papers/8189527PubMed
8189506The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.J Virol1994https://conductscience.org/library/papers/8189506PubMed
8057475Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization.J Virol1994https://conductscience.org/library/papers/8057475PubMed
7533680Anti-V3 antibody reactivity correlates with clinical stage of HIV-1 infection and with serum neutralizing activity.Clin Exp Immunol1995https://conductscience.org/library/papers/7533680PubMed
7494310Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program.J Virol1995https://conductscience.org/library/papers/7494310PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700

Source NCBI Gene

Download CSV of genes

Data30

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKP80112GENBANK
GENBANKP80113GENBANK
GENBANKP80114GENBANK
GENBANKP80115GENBANK
GENBANKP80116GENBANK
GENBANKP80117GENBANK
GENBANKP80118GENBANK
GENBANKP80119GENBANK
GENBANKP80120GENBANK
GENBANKP80121GENBANK
GENBANKP80122GENBANK
GENBANKP80123GENBANK
GENBANKP80124GENBANK
GENBANKP80125GENBANK
GENBANKP80126GENBANK
GENBANKP80127GENBANK
GENBANKP80128GENBANK
GENBANKP80129GENBANK
GENBANKP80130GENBANK
GENBANKP80131GENBANK

See all 30 dataDownload CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8437232

GET https://conductscience.org/api/papers/v1/8437232/references?page=2